Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03425201
Title Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA) (NICARAGUA)
Acronym NICARAGUA
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fundacion CRIS de Investigacion para Vencer el Cancer
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.